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Abstract The single stranded [3H]oligonucleotide uptake by
HL-60 human promyelocyte and K562 human erythroleukemia
cells was stimulated 20^45-fold by DUSF (DNA uptake
stimulating protein), and this effect was drastically reduced (to
1.6^13U) if the cells were induced to differentiate. The
oligonucleotide uptake stimulating effect of DUSF was not
altered in HL-60 and K562 cells, if the proliferation of the cells
was inhibited by hydroxyurea (HU) treatment. The oligonucleo-
tide uptake by separated granulocytes and mononuclear cells
from healthy donors was not stimulated by DUSF, while the
uptake of oligonucleotides by myeloid and lymphoid leukemic
cells was greatly stimulated (10^15U). The uptake of oligonu-
cleotides by differentiated mononuclear cells of healthy donors
could not be stimulated by DUSF, but the oligonucleotide uptake
was greatly increased (11U) by DUSF if the cells were subjected
to blast transformation.
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1. Introduction
It has been known since more than a decade that mamma-
lian cells can take up DNA and oligonucleotides, although the
molecular mechanism of uptake and its biological relevance
have remained obscure [1^4]. The introduction of antisense
oligonucleotides into mammalian cells is thought to be of
major therapeutic importance in the future [5,6]. Antisense
oligonucleotides may speci¢cally inhibit virus propagation,
division of tumor cells, or the expression undesirable genes
by annealing to coding sequences of DNA or to mRNA
[7,8]. A limitation of application of antisense oligonucleotides
is based upon the low level of uptake by mammalian cells
under physiological conditions. Therefore the stimulation of
uptake would be desirable.
In a previous publication the occurrence of a natural DNA
uptake stimulatory factor (DUSF), a protein molecule that
appears in the culture medium of Neurospora crassa strain
(FGSC 1118, slime) was reported [9]. DUSF was puri¢ed to
homogeneity, biochemically characterized [10], and found to
be a cytoplasmic membrane associated protein able to bind
DNA and nucleotides [11]. The optimal conditions of DUSF
action were described and its possible biological role in the
uptake of DNA and oligonucleotides was discussed [11]. It
was also described (i) that DUSF was able to stimulate oli-
gonucleotide and linearized pBR322 plasmid DNA uptake
into mammalian tumor cells in vitro; (ii) it has also been
demonstrated that macromolecular DNA was not degraded
during the uptake process; and (iii) DUSF antigen could
also be detected in the cytoplasmic membrane of these malig-
nant cells [12].
In this paper we demonstrate that DUSF does stimulate
single stranded (ss) [3H]oligonucleotide uptake by primitive
leukemia cells, while it shows very limited activity with respect
to di¡erentiated forms.
2. Materials and methods
2.1. Cell cultures
HL-60 human promyelocytic, K562 human erythroleukemia, and
human mononuclear cells were propagated in RPMI 1640 medium
(Gibco, USA) supplemented either with 20% (HL-60) or with 10%
(K562, mononuclear cells) fetal calf serum (SEBAK, Germany), in
plastic petri dishes having a diameter of 9 cm (Greiner, Germany).
The media were also supplemented with penicillin, streptomycin and/
or gentamycin. All mammalian cell cultures were maintained at 37‡C
in a humidi¢ed atmosphere containing 5% CO2.
2.2. Preparation of DUSF and single stranded [3H]oligonucleotides
The DNA-uptake-stimulating protein (DUSF) was isolated from
the culture medium of N. crassa cell-wall-less mutant strain (FGSC
1118 [fz; sg; os-1, slime]) as described earlier [10]. The mixture of ss
[3H]oligonucleotides was produced by limited digestion of [3H]DNA
(extracted from N. crassa cells grown in the presence of [3H]adenine)
with bovine pancreas DNase I (Sigma) 25 Wg/ml at 37‡C, for 60 min.
After termination of the enzyme treatment the [3H]oligonucleotides
were denatured at 100‡C for 10 min and immediately chilled in a
0‡C ice bath. The ss [3H]oligonucleotides were separated from the
reaction mixture by Sephadex G75 gel ¢ltration and their polyacryl-
amide gel electrophoresis characterization revealed approximately 10^
40-bp long fragments.
2.3. Uptake of single stranded [3H]oligonucleotides
Cells were washed three times in Hank’s bu¡er and then a suspen-
sion of 3U106 cells/ml in the same bu¡er was prepared. Incubation
mixture consisted of 1 ml cell suspension, 0.02 ml DUSF (20 Wg) or
fresh medium and 0.01 ml of ss [3H]oligonucleotides (10 Wg). Incuba-
tion was carried out with shaking in a water bath at 37‡C for 2 h. The
uptake was terminated by rapid cooling of the samples for 10 min at
0‡C. [3H]Oligonucleotides not taken up by the cells were eliminated by
the addition of 0.2 mg DNase I for 10 min at 37‡C, and immediately
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washed o¡ in four repeats of 0.5 M NaCl at 0‡C. Finally the cells
were dried in the centrifuge tubes. The radioactivity of the samples
was measured as in [11]. Data shown in the tables are the mean
values þ S.D. of three separate determinations.
2.4. Human granulocyte and mononuclear cell suspensions
Granulocytes were separated from heparinized venous blood sam-
ples obtained from voluntary healthy donors and patients with
chronic granulocytic leukemia (CGL), in the blast phase of their dis-
ease [13]. These human white blood cell (WBC) suspensions used in
the experiments consisted of 95% granulocytes and 5% mononuclears
but no red blood cells.
Mononuclears were separated from heparinized venous blood of
voluntary healthy donors and patients with B-cell chronic lymphoid
leukemia (B-CLL) [14]. The ¢nal mononuclear cell suspension of
healthy donors consisted of 70^80% lymphocytes and 20^30% mono-
cytes, while that of the B-CLL patients contained 95% lymphoid cells
(the majority of them being morphologically di¡erentiated) and 5%
monocytes. Trypan blue exclusion test was performed to determine
the viable cell fraction [15], which demonstrated 90^95% viability.
2.5. Di¡erentiation of HL-60 and K562 cells in vitro
HL-60 human promyelocytic leukemia cells which grow in suspen-
sion in vitro are ready to undergo di¡erentiation into macrophage-like
cells [16]. 72 h after the addition of O-tetradecanoylphorbol-13-acetate
(TPA, Sigma, ¢nal concentration 300 nM) to the medium nearly 100%
of the cells became adherent to the bottom of the tissue culture dish
and exhibited positive alpha-naphthylacetate esterase reaction as signs
of di¡erentiation [17]. Cells adhering to the plastic surface were
scraped o¡ by a rubber policeman and resuspended in fresh medium.
85^90% of the cells proved to be viable by the trypan blue dye ex-
clusion test.
K562 human erythroleukemia cells were di¡erentiated towards the
erythroid route by addition of cytosine-L-D-arabinofuranoside (Ara-C,
Sigma, ¢nal concentration 10 WM) to the culture medium [18]. 72 h
later the cells were collected by centrifugation (500 rpm, 5 min, 37‡C)
and resuspended in fresh medium. The di¡erentiation of the cells and
its degree was estimated by the detection of embryonic and fetal
hemoglobins within the cells by means of the benzidine reaction
[18]. 68% of the Ara-C treated cells became benzidine positive while
in the untreated control cultures their proportion was only 10%. 85%
of the treated cells proved to be viable by the trypan blue dye exclu-
sion test.
2.6. Blast transformation of lymphocytes
From heparinized venous blood of a healthy donor mononuclear
cells were separated [14]. The cells were washed three times in RPMI
1640 medium containing 10% fetal calf serum, and resuspended in the
same medium at a cell density of 106 cells/ml. The suspension was
divided into two equal portions and cultivated in the presence or
absence (control) of phytohemagglutinin (PHA, Sigma, ¢nal concen-
tration 0.2 Wg/ml) for 72 h as described above. Cell proliferation was
followed by measuring [3H]thymidine incorporation. PHA-treated
cells after 72 h in culture incorporated 5 times more [3H]thymidine
than the controls. 90% of the cells in the parallel cultures proved to be
viable by the trypan blue dye exclusion test.
3. Results and discussion
It was described previously [12] that DUSF stimulated oli-
gonucleotide uptake by proliferating human HL-60 promye-
locytic and K562 erythroleukemic cells in vitro. It remained
intriguing, however, to see whether DUSF was able to stim-
ulate oligonucleotide uptake of these cells in their di¡erenti-
ated state as well. HL-60 cells were switched to di¡erentiate
towards the macrophage route by TPA, while K562 cells were
induced in the direction of erythroid development by Ara-C,
and their oligonucleotide uptake was measured in the presence
and absence of DUSF.
It is shown in Table 1 that the ss [3H]oligonucleotide uptake
stimulating e¡ect of DUSF almost completely disappeared in
the case of di¡erentiated HL-60 cells, and with K562 di¡er-
entiated cells a merely 1/3 stimulation could be seen compared
to the proliferating undi¡erentiated cells. This lower degree of
uptake, however, remained still comparable with that of the
di¡erentiated HL-60 cells. Two factors may be considered in
the explanation of that di¡erence: (i) both the basal and the
DUSF-stimulated oligonucleotide uptake of the K562 cells are
considerably higher, several times more than that of the pro-
liferating HL-60 cells ; and (ii) the degree of di¡erentiation in
the HL-60 culture was almost 100% as determined by cyto-
chemical reaction, while the K562 population seemed to be
more heterogeneous in this aspect showing signs of di¡eren-
tiation only in 68% of the Ara-C treated cells (see Section 2).
It seems very likely that the oligonucleotide uptake stimula-
tory e¡ect of DUSF decreases or even ceases with the tran-
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Table 1
The e¡ect of DUSF on the uptake of ss [3H]oligonucleotides by proliferating undi¡erentiated and di¡erentiated mammalian cells
Mammalian cells Uptake of ss [3H]oligonucleotides (dpm/mg dried cell þ S.D.)
Proliferating undi¡erentiated cells Di¡erentiated cells
3DUSF +DUSF Stimulation 3DUSF +DUSF Stimulation
HL-60 105 þ 15 2106 þ 156 20.0U 287 þ 50 448 þ 65 1.6U
K562 223 þ 36 10 115 þ 280 45.4U 276 þ 20 3640 þ 173 13.2U
In vitro proliferating undi¡erentiated tumor cells were di¡erentiated by the addition of TPA (HL-60 cells) or Ara-C (K562 cells), respectively, as
described in Section 2. The uptake of [3H]oligonucleotides (10 Wg/ml) was measured in the absence (3) and in the presence (+) of DUSF (20 Wg/ml).
Data represent the mean þ S.D. of three separate determinations.
Table 2
Proliferation (A) and ss [3H]oligonucleotide uptake (B) in hydroxy-
urea-treated HL-60 cells in the presence and absence of DUSF
A Untreated Hydroxyurea-
treated
0 h 24 h 0 h 24 h
Cell number (U105/ml) 0.77 2.31 0.77 1.19
Increase of cell number (%) 100 300 100 155
Trypan blue positivity (%) 10 12 10 13
B Uptake of ss [3H]oligonucleotides
(dpm/mg dried cell þ S.D.)
Untreated Hydroxyurea-
treated
3DUSF 120 þ 20 100 þ 30
+DUSF 2663 þ 135 2846 þ 170
Suspensions of HL-60 cells proliferating in vitro were split and to one
half of the cultures HU was added at a ¢nal concentration of 0.2 mM.
The other halves served as controls. The cells were further cultivated
for another 24 h. The viability of the cells was estimated by the trypan
blue exclusion test [14]. The [3H]oligonucleotide uptake was deter-
mined in the absence (3) and in the presence (+) of DUSF (20 Wg/
ml) as described in Section 2. Data represent the mean þ S.D. of three
separate determinations.
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sition of the tumor cells from the primitive proliferating to the
di¡erentiated stage.
It is well known that malignant cells divide frequently, and
their di¡erentiation is accompanied by a decrease in the rate
of proliferation. Thus it proved itself a challenging problem to
establish whether the decrease of the oligonucleotide stimulat-
ing ability of DUSF in the case of TPA and Ara-C treated
leukemic cells could be considered as a consequence of di¡er-
entiation of those tumor cells, or it was connected to the
cessation of cell proliferation.
In order to address that question we studied the ss
[3H]oligonucleotide uptake in the normally proliferating state
of the tumor cells as well as when their propagation was
inhibited. HL-60 and K562 cells were cultivated either in the
presence or in the absence of hydoxyurea (HU) for 20 h prior
to the determination of oligonucleotide uptake with and with-
out the DUSF. (HU is a potent inhibitor of the enzyme ribo-
nucleotide reductase and thus of DNA synthesis, and it halts
progression through the cell cycle evoking cessation at the G1/
S boundary [19].)
Parts ‘A’ in Table 2 and in Table 3 as well, show a marked
decrease in the proliferation of HL-60 and K562 cells, respec-
tively, without diminishing the viability of the cells. The
trypan blue exclusion test did not show di¡erences between
the HU-treated and non-treated cells. In parts ‘B’ of
Tables 2 and 3, respectively, we demonstrate that the basal
and the DUSF-stimulated [3H]oligonucleotide uptake was es-
sentially the same in the HU-treated, in their propagation
blocked tumor cells and in the non-treated, proliferating cul-
tures.
These results may suggest us that the decrease of the stim-
ulating e¡ect of DUSF is rather the consequence of the di¡er-
entiation of the tumor cells than it would be the result of the
inhibition of cell proliferation. It has to be noted, however,
that di¡erentiation of tumor cells is accompanied by their
lower rate of proliferation.
From a practical point of view it seemed to be of utmost
importance to compare the e¡ect of DUSF upon oligonucleo-
tide uptake by normal and tumor cells of human origin. To
address this question granulocytic and lymphoid cells were
separated from the blood of patients either with blast phase
CGL or B-CLL, respectively. Normal granulocytes and
mononuclear cells were obtained from peripheral blood of
healthy donors. The uptake of ss [3H]oligonucleotides by these
cell populations was measured in the presence and absence of
DUSF.
It is shown in Fig. 1 that DUSF failed to stimulate oligo-
nucleotide uptake by normal granulocytes and lymphocytes
but the uptake was considerably enhanced in the case of leu-
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Fig. 1. The e¡ect of DUSF on the uptake of ss [3H]oligonucleotides
by human granulocytes and mononuclears of healthy donors or leu-
kemic patients. Granulocyte and mononuclear cell suspensions were
prepared from venous blood of healthy donors (controls) as well as
from patients with chronic granulocytic leukemia (CGL) or B-cell
chronic lymphoid leukemia (B-CLL), as described in Section 2. The
uptake of [3H]oligonucleotides (10 Wg/ml) by these cells was deter-
mined in the absence (a) and in the presence (b) of DUSF (20 Wg/
ml). Each symbol represents the mean of three determinations
( þ S.D.). Cell samples of donors were halved and determinations of
[3H]oligonucleotide uptake were made on the same populations re-
garding the presence and absence of DUSF (see Section 2).
Table 4
The e¡ect of DUSF on ss [3H]oligonucleotide uptake in control and in PHA-treated mononuclear cell populations
Mononuclear cells Uptake of ss [3H]oligonucleotides (dpm/106 cells)
3DUSF +DUSF Stimulation
Non-treated 211 þ 27 372 þ 32 1.7U
PHA-treated 428 þ 15 4606 þ 142 10.8U
Mononuclear cells were separated from venous blood of healthy donors. Half of the cell suspension was treated by phytohemagglutinin (PHA, 0.2
Wg/ml) as described in Section 2. The uptake of [3H]oligonucleotides (10 Wg/ml) by these cells was determined in the absence (3) and in the presence
(+) of DUSF (20 Wg/ml). Data represent the mean þ S.D. of three separate determinations.
Table 3
Proliferation (A) and ss [3H]oligonucleotide uptake (B) in hydroxy-
urea-treated K562 cells in the presence and absence of DUSF
A Untreated Hydroxyurea-
treated
0 h 24 h 0 h 24 h
Cell number (U105/ml) 0.82 2.07 0.82 1.01
Increase of cell number (%) 100 252 100 123
Trypan blue positivity (%) 10 12 12 14
B Uptake of ss [3H]oligonucleotides
(dpm/mg dried cell þ S.D.)
Untreated Hydroxyurea-
treated
3DUSF 110 þ 20 140 þ 30
+DUSF 4736 þ 174 4530 þ 298
Suspensions of K562 cells proliferating in vitro were split and to one
half of the cultures HU was added at a ¢nal concentration of 5 mM.
The other halves served as controls. The cells were further cultivated
for another 24 h. The viability of the cells was estimated by the trypan
blue exclusion test [14]. The [3H]oligonucleotide uptake was deter-
mined in the absence (3) and in the presence (+) of DUSF (20 Wg/
ml) as described in Section 2. Data represent the mean þ S.D. of three
separate determinations.
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kocytes from CGL and B-CLL patients in the blast phase.
This apparent di¡erence might be due to the fact that there
are ultimately di¡erentiated WBCs in the circulation of
healthy individuals, while some of the WBCs in the peripheral
blood of malignant myeloid or lymphoid leukemia patients
are undi¡erentiated progenitor cells [20^22]. In our experi-
ments smears of cells isolated from patients’ blood samples
revealed more than 35% blast phase primitive cells in cytolog-
ical analysis.
Our observations are in good agreement with results of
other authors who (i) reported that oligonucleotide uptake
was stage-speci¢c during B cell di¡erentiation, namely, an
enhanced oligonucleotide uptake ability in B progenitor cells
in bone marrow was detected as compared to low values ex-
perienced in mature B cells [23] ; (ii) described enhanced oli-
gonucleotide uptake by in vitro proliferating tumor cells iso-
lated originally from acute myeloid or lymphoid leukemia
patients, compared to healthy counterparts [24].
Based on the results shown in Table 1 and in Fig. 1 it was
assumed that DUSF was unable ^ or had a very limited abil-
ity ^ to stimulate oligonucleotide uptake by di¡erentiated
cells, and it was predominantly active with cells progressing
through the cell cycle. This hypothesis was tested in the fol-
lowing experiment.
Mononuclear cells were separated from venous blood of
healthy donors. The cell suspensions were split into two equal
parts, one being induced by the mitogen PHA and the other
not (control). Each of the suspensions were further split into
two equal parts, and the ss [3H]oligonucleotide uptake was
determined in the presence and absence of DUSF. Table 4
shows that the oligonucleotide uptake stimulating e¡ect of
DUSF was almost negligible in the case of di¡erentiated cells
while it was substantial in the mitogen induced blast trans-
formation population.
Previous reports by others have already described enhanced
oligonucleotide uptake by mitogen (concanavalin A or lipo-
polysaccharide) stimulated T and B lymphocytes [25,26]. It
was recently published by Zhao et al. [24] that proliferating
bone marrow cells stimulated by hematopoietic growth factors
(interleukin-3, stem cell factor) showed considerably enhanced
oligonucleotide uptake on the one hand, and on the other, in
HL-60 cells the oligonucleotide uptake was decreased by the
induction of cell di¡erentiation with all-trans-retinoic acid.
The results cited as well as our observations are suggestive
of a possible correlation between the oligonucleotide uptake
ability of mammalian cells and their activated and/or di¡er-
entiated stage.
The oligonucleotide uptake stimulating potential of DUSF
seems to us to be predominantly e¡ective in undi¡erentiated
in vitro proliferating leukemic cells (Table 1), in malignant
tumor cells (Fig. 1), and in mitogen blast transformed lym-
phocytes (Table 2), while this protein remained practically
ine¡ective in di¡erentiated cell populations (cells induced to
di¡erentiate in vitro, normal WBCs). The ability of cells to
take up oligonucleotides from their environment seems to be
dissimilar in the di¡erentiated and in the primitive proliferat-
ing state. It has not been possible to determine the real cause
of this phenomenon yet, on the one hand, and on the other it
is rather plausible to assume the expression of proteins in-
volved in oligonucleotide uptake being higher in primitive,
undi¡erentiated state of tumor cells.
Several proteins have already been detected on the surface
of a number of various eukaryotic cells which are able to bind
nucleic acids, but their eventual role in the uptake of nucleic
acids has not been proved yet [27^29]. To our recent knowl-
edge DUSF is the only isolated protein which is able to en-
hance the uptake of oligonucleotides (and macromolecular
DNA) into mammalian cells. DUSF might act for instance
as a receptor protein, since (i) DUSF proved to be capable to
bind DNA and nucleotides as well, and these molecules show
a competition in that binding reaction, (ii) the presence of
DUSF has been demonstrated on the surface of mammalian
cells including tumor cells as well, and (iii) anti-DUSF anti-
bodies have been shown to be capable to inhibit basal- and
DUSF-stimulated uptake of DNA/oligonucleotides in tumor
cells [11,12].
The fact that DUSF is capable to increase the uptake of
single stranded oligonucleotide(s) by primitive leukemic cells,
may give some good hope of an eventual promotive e¡ect in
the uptake of proliferation inhibiting antisense oligonucleo-
tides as well.
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